JCO Precis Oncol 2022 Apr
Comprehensive Genomic Profiling ofHigh-Risk Pediatric Cancer Patients Has aMeasurable Impact on Clinical Care
Related Questions
Do you plan to change your practice based on the data presented in this JCO paper by Summers et al?
New answer by at Winship Cancer Institute of Emory University (October 20, 2022)
As mentioned in our article, we currently offer tumor genomic sequencing to patients who have high risk pediatric cancers at diagnosis who do not routinely undergo molecular c...
New answer by at Dana-Farber Cancer Institute (November 29, 2022)
I imagine this answer, as often is the case in the setting of great complexity, is "it depends." Genomic sequencing is far less expensive than it was previously, but it remain...